Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Alphagan P 1.5
Active Ingredient:	Brimonidine tartrate 1.5mg/mL
Dosage Form:	Eye drops, solution
New Zealand Sponsor:	AbbVie Limited
Manufacturer:	Allergan Sales LLC, Texas, United States of America

*Product:*	Keytruda
Active Ingredient:	Pembrolizumab 25mg/mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Merck Sharp & Dohme (New Zealand) Limited
Manufacturers:	MSD International GmbH (Singapore Branch), Singapore MSD International GmbH, t/a MSD Ireland (Carlow), Carlow, Ireland

Dated this 16th day of January 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule